The retrospective study analyzed data on 149 patients with CTCL who were being managed at one of nine international academic medical centers in seven countries from March through October 2020.
A new analysis found that patients diagnosed with a second primary melanoma were more likely to have a nevus phenotype and a higher risk score than those who only had a primary melanoma.